Skip to main content
Plenary session at #ACR25!

#0772 When should we biopsy in SLE?
In pts with uPCR 0.25-0.49 g/g + LN predictors, 69% alre

Mrinalini Dey DrMiniDey

9 months 1 week ago
Plenary session at #ACR25! #0772 When should we biopsy in SLE? In pts with uPCR 0.25-0.49 g/g + LN predictors, 69% already had LN (many Class III/V). Low C3/C4 were most important factors. 0.5 g/g cutoff may delay diagnosis and treatment. Time to rethink thresholds? @RheumNow
#LLM can be #virtual #tutor for
👇
#OSCE

RCT - better competence &confidence

#AI & #medical #education

AI

Janet Pope Janetbirdope

9 months 1 week ago
#LLM can be #virtual #tutor for 👇 #OSCE RCT - better competence &confidence #AI & #medical #education AI trained to #tutor Also grading OSCE #AI + human @RheumNow @ACRheum #26S17 https://t.co/CzKoxyjpY8
Early, low level proteinuria is a harbinger in SLE. ~50% with elevated UPCR but <0.5 had actionable LN on early bx.

Brian Jaros, MD Dr_Brian_MD

9 months 1 week ago
Early, low level proteinuria is a harbinger in SLE. ~50% with elevated UPCR but <0.5 had actionable LN on early bx. Risk factor = low c3/c4 Urine biomarkers promising #ACRBest #ACR25 @RheumNow https://t.co/WuNPKeqeid
#Pros and #cons of #AI

Need to know both
Need to assess AI #quality and #accuracy

‘Assume AI WILL be used’
JHausm

Janet Pope Janetbirdope

9 months 1 week ago
#Pros and #cons of #AI Need to know both Need to assess AI #quality and #accuracy ‘Assume AI WILL be used’ JHausmann By trainees, patients and medical personnel Train #faculty re #AI #ACR25 @RheumNow @ACRheum #26S17 https://t.co/CvPDQPbueW
What's new in the Pre-RA world?
Slowly unraveling mechanisms and biology associated to transition from CCP+ asymptomati

Aurelie Najm AurelieRheumo

9 months 1 week ago
What's new in the Pre-RA world? Slowly unraveling mechanisms and biology associated to transition from CCP+ asymptomatic pre-RA state to clinical RA Here is my summary of a few abstracts presented at #ACR25 proposing biomarkers beyond the realm of clinical and classical
From Dr. Petri at Plenary - even small amounts of proteinuria are a PROBLEM. Reduction of microalbuminuria by even 10% i

Brian Jaros, MD Dr_Brian_MD

9 months 1 week ago
From Dr. Petri at Plenary - even small amounts of proteinuria are a PROBLEM. Reduction of microalbuminuria by even 10% improves mortality! #ACR25 @RheumNow https://t.co/hjmH26vXIb
#AI for medical use is fast moving

governance is Impt

Protect Privacy
Facilitate trainees to LEARN
Involve #IT, ethici

Janet Pope Janetbirdope

9 months 1 week ago
#AI for medical use is fast moving governance is Impt Protect Privacy Facilitate trainees to LEARN Involve #IT, ethicists, users ‘We will enter a world where all we do medically is recorded’ J Hausmann said #ACR25 @RheumNow @ACRheum #26S17 https://t.co/zWjy4u99Yo
#Medical #learners more optimistic re #AI than gen pop’n!

Tips
stress privacy
- pt info in AI goes to private company

Janet Pope Janetbirdope

9 months 1 week ago
#Medical #learners more optimistic re #AI than gen pop’n! Tips stress privacy - pt info in AI goes to private company All trainees will use #AI Set boundaries - change eval where can’t use AI only AI listening notes 👇 #cognitive #deskilling #ACR25 @RheumNow @ACRheum 26S17 https://t.co/UzajaimOcG
For #SLE pleuropericarditis: recommendation intentionally tries to leverage use of colchicine/NSAIDs vs. GCs
But there a

sheila RHEUMarampa

9 months 1 week ago
For #SLE pleuropericarditis: recommendation intentionally tries to leverage use of colchicine/NSAIDs vs. GCs But there are special situations where GCs are req’d: > Concomitant active SLE > CI to NSAIDs/Col > Recurrent pericarditis > Late pregnancy > 💊interxns #ACR25 @RheumNow https://t.co/sLL72t3Qhf
HIGH YIELD🚨Summary of Organ Specific Recommendations-ACR guidelines for Management of SLE by Dr Lisa Sammaritano. @Rh

Gabriela Martinez Zayas, MD MartinezZayasMd

9 months 1 week ago
HIGH YIELD🚨Summary of Organ Specific Recommendations-ACR guidelines for Management of SLE by Dr Lisa Sammaritano. @RheumNow #ACR2025 https://t.co/ysSTKOz1ym
Year in Review: Regency Trial showed that LN pts given obinutuzumab achieved CRR at 76 wks (46.4%) vs. PBO.

Take note:

sheila RHEUMarampa

9 months 1 week ago
Year in Review: Regency Trial showed that LN pts given obinutuzumab achieved CRR at 76 wks (46.4%) vs. PBO. Take note: the Regency trial did not evaluate the extrarenal effects of Obinutuzumab in #SLE, thats for a diff study. #ACR25 @RheumNow https://t.co/WJssU1DbzZ
Artificial intelligence isn’t a distant frontier anymore. It’s here, and it appears able to detect signs of rheumatoid arthritis, possibly before we can clinically detect it. Two studies presented at this year’s ACR meeting highlight just how close we may be to a future where algorithms flag disease before we can and monitor activity with minimal patient burden.
High-resolution ultrasound detected subclinical enthesitis in 44% of psoriasis patients without arthritis and 12% had PD

Antoni Chan MD (Prof) synovialjoints

9 months 1 week ago
High-resolution ultrasound detected subclinical enthesitis in 44% of psoriasis patients without arthritis and 12% had PD positivity. Supports a preclinical PsA phase and use of MSUS to detect entheseal inflammation in both symptomatic and asymptomatic PsO patients for timely
#ACR25 New ACR Non-Renal #SLE lifecourse Guideline. 3 strong recommendations:

- HCQ routinely unless contraindicated
-

Md Yuzaiful Md Yusof Yuz6Yusof

9 months 1 week ago
#ACR25 New ACR Non-Renal #SLE lifecourse Guideline. 3 strong recommendations: - HCQ routinely unless contraindicated - Taper GC to =< 5mg/d - Escalate therapy in any organ system if refractory to initial therapy *Organ-specific: Conditional recommendations only @RheumNow https://t.co/w9rfcvwGHy
×